Has IME been doing, and continue to do, a lot R&D? Just looking at the historical financials and see revenue for the last 6 years from 2018, 5.8m, 7.7, 10.9, 13.3, 17.1 and 19.67 for 2023, but losses continue ranging from -4.9, -6.0 to still -4.1 for 2023. I have had this on the watchlist for over 12 months and see comments in this thread about late payments, but that doesn't explain multi-year.
I can see a lot of shares being issued, and a consolidation in 2019 confusing things a bit, but is it a case of R&D upgrading, or takeovers of smaller competitors?
Ann: 2024 Q1 Quarterly Activities Report and Appendix 4C, page-21
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.31M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 8300 | 1 |
View Market Depth
| Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
| IME (ASX) Chart |
Day chart unavailable